JP2006525299A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006525299A5 JP2006525299A5 JP2006506208A JP2006506208A JP2006525299A5 JP 2006525299 A5 JP2006525299 A5 JP 2006525299A5 JP 2006506208 A JP2006506208 A JP 2006506208A JP 2006506208 A JP2006506208 A JP 2006506208A JP 2006525299 A5 JP2006525299 A5 JP 2006525299A5
- Authority
- JP
- Japan
- Prior art keywords
- azetidine
- alkyl
- pharmaceutical composition
- aryl
- carboxamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0310052 | 2003-05-01 | ||
| PCT/GB2004/001884 WO2004096794A1 (en) | 2003-05-01 | 2004-04-29 | Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disordrs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006525299A JP2006525299A (ja) | 2006-11-09 |
| JP2006525299A5 true JP2006525299A5 (enExample) | 2007-06-21 |
Family
ID=33397040
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006506208A Pending JP2006525299A (ja) | 2003-05-01 | 2004-04-29 | アゼチジンカルボキサミド誘導体及びｃｂ１レセプター媒介障害の治療におけるその使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US20070173486A1 (enExample) |
| EP (1) | EP1618105A1 (enExample) |
| JP (1) | JP2006525299A (enExample) |
| WO (1) | WO2004096794A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004252109B2 (en) | 2003-06-11 | 2010-04-08 | Merck Sharp & Dohme Corp. | Substituted 3-alkyl and 3-alkenyl azetidine derivatives |
| US20060025448A1 (en) | 2004-07-22 | 2006-02-02 | Cadila Healthcare Limited | Hair growth stimulators |
| US7906652B2 (en) | 2005-11-28 | 2011-03-15 | Merck Sharp & Dohme Corp. | Heterocycle-substituted 3-alkyl azetidine derivatives |
| AU2007283113A1 (en) | 2006-08-08 | 2008-02-14 | Sanofi-Aventis | Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use |
| EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| UY31968A (es) | 2008-07-09 | 2010-01-29 | Sanofi Aventis | Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos |
| JP5079630B2 (ja) | 2008-08-08 | 2012-11-21 | 株式会社小松製作所 | 排気ガス浄化装置 |
| JP5033736B2 (ja) | 2008-08-08 | 2012-09-26 | 株式会社小松製作所 | 排気ガス浄化装置 |
| WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
| KR20120060207A (ko) | 2009-08-26 | 2012-06-11 | 사노피 | 신규한 결정성 헤테로방향족 플루오로글리코시드 수화물, 이들 화합물을 포함하는 약제 및 이들의 용도 |
| EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
| EP2683704B1 (de) | 2011-03-08 | 2014-12-17 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120058A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| US8710050B2 (en) | 2011-03-08 | 2014-04-29 | Sanofi | Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
| US8809325B2 (en) | 2011-03-08 | 2014-08-19 | Sanofi | Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof |
| EP2766349B1 (de) | 2011-03-08 | 2016-06-01 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| EP2683703B1 (de) | 2011-03-08 | 2015-05-27 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| EP2683702B1 (de) | 2011-03-08 | 2014-12-24 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| EP2671870A1 (en) * | 2012-06-05 | 2013-12-11 | Bioprojet | Novel (aza)benzhydryl ether derivatives, their process of preparation and their use as H4-receptor ligands for therapeutical applications |
| US11141404B1 (en) | 2020-11-18 | 2021-10-12 | Anebulo Pharmaceuticals, Inc. | Formulations and methods for treating acute cannabinoid overdose |
| AU2022362107A1 (en) | 2021-10-11 | 2024-05-02 | Anebulo Pharmaceuticals, Inc. | Crystalline forms of a cannabinoid receptor type 1 (cb1) modulator and methods of use and preparation thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| YU39992B (en) * | 1976-04-02 | 1985-06-30 | Janssen Pharmaceutica Nv | Process for obtaining new piperazine and piperidine derivatives |
| US4261990A (en) * | 1979-03-09 | 1981-04-14 | Ciba-Geigy Corporation | N-alkyleneiminoalkyl-dicarboximides as antiallergics and antiasthmatics |
| CA2015949A1 (en) * | 1989-05-22 | 1990-11-22 | Yasuo Ito | Piperidine derivative, method for preparation thereof, and a pharmaceutical composition comprising the same |
| JPH03264562A (ja) * | 1989-05-22 | 1991-11-25 | Hokuriku Seiyaku Co Ltd | ピペリジン誘導体 |
| JPH09278737A (ja) * | 1996-02-16 | 1997-10-28 | Tanabe Seiyaku Co Ltd | フェノール誘導体及びその製法 |
| JP3194355B2 (ja) * | 1996-10-24 | 2001-07-30 | 宇部興産株式会社 | ピペリジン化合物及びその製法 |
| AU7079998A (en) * | 1997-04-25 | 1998-11-24 | Takeda Chemical Industries Ltd. | Condensed pyridazine derivatives, their production and use |
| EP1049672B1 (en) * | 1998-01-23 | 2003-09-17 | Vernalis Research Limited | Azetidinecarboxamide derivatives for treating cns disorders |
| CA2319435A1 (en) * | 1998-12-04 | 2000-06-15 | Toray Industries, Inc. | Triazolo derivatives and chemokine inhibitors containing the same as effective component |
| GB9917386D0 (en) * | 1999-07-23 | 1999-09-22 | Cerebrus Ltd | Chemical compounds-II |
| AU2002347906A2 (en) * | 2001-10-16 | 2003-04-28 | Hypnion, Inc. | Treatment of CNS disorders using CNS target modulators |
-
2004
- 2004-04-29 WO PCT/GB2004/001884 patent/WO2004096794A1/en not_active Ceased
- 2004-04-29 JP JP2006506208A patent/JP2006525299A/ja active Pending
- 2004-04-29 EP EP04730303A patent/EP1618105A1/en not_active Withdrawn
- 2004-04-29 US US10/554,447 patent/US20070173486A1/en not_active Abandoned
-
2009
- 2009-03-19 US US12/407,021 patent/US20090181939A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006525299A5 (enExample) | ||
| TWI409261B (zh) | 經取代之苯甲醯胺衍生物 | |
| AU2012313254B8 (en) | Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors | |
| RU2569887C2 (ru) | Производные оксазолинов для лечения расстройств цнс | |
| US20040152754A1 (en) | Cyclic AMP-specific phosphodiesterase inhibitors | |
| CN1440402A (zh) | 作为趋化因子受体活性调节剂的n－脲基杂环烷基－哌啶 | |
| JP2006525298A5 (enExample) | ||
| JP2013516415A5 (enExample) | ||
| RU2011115111A (ru) | Замещенные пирролидин-2-карбоксамиды | |
| JP2005526723A5 (enExample) | ||
| WO2007052843A1 (ja) | 複素環アミド化合物およびその用途 | |
| CN107001259B (zh) | 作为taar配体的取代的氮杂环丁烷衍生物 | |
| JP2017524026A5 (enExample) | ||
| RU2009138219A (ru) | Новые бензамидные производные и способ их получения | |
| CN104024250A (zh) | 作为痕量胺相关受体(taar)的杂环衍生物 | |
| JP6186495B2 (ja) | Ｃｅｔｐ抑制活性を有する新規なオキサゾリジノン誘導体、その製造方法およびこれを含む薬学組成物 | |
| RU2625798C2 (ru) | Производные (3-метилпирролидин-3-ил)-метил пиридинилового эфира и их применение в качестве антагонистов рецептора nk-3 | |
| JP5677457B2 (ja) | ピロリジン誘導体 | |
| RU2690154C2 (ru) | Производные морфолин-пиридина | |
| JP2011524397A (ja) | Ｎｋ受容体アンタゴニストとしてのピロリジン誘導体 | |
| CA2713412C (en) | Amide derivative and pharmaceutical composition containing the same | |
| RU2006135486A (ru) | Производные n-пиперидина в качестве модуляторов ссr3 | |
| JP2011529871A (ja) | チオフェン−２−カルボキサミド誘導体、これらの調製およびこれらの治療的使用 | |
| JP2010514824A (ja) | 置換ｎ−（４−シアノ−１ｈ−ピラゾール−３−イル）メチルアミン誘導体、これらの調製およびこれらの治療的使用 | |
| JP5156806B2 (ja) | アミド誘導体からなる医薬 |